← Latest papers
📄 cell biology

Oxidized TRX1 and DPP8/9 stabilize the MIA40-AIFM1 complex during intrinsic apoptosis

This study reveals that oxidized TRX1 and active DPP8/9 cooperatively stabilize the MIA40-AIFM1 complex through redox-dependent assembly and selective proteolysis of competing ligands, thereby reinforcing NLRP1 restraint to ensure immunologically silent intrinsic apoptosis.

Original authors: Tsamouri, L. P., Geeson, M. B., Teplova, M., Li, B., Lai, Z., Tellez, A. V., Ball, D. P., Chakravarti, A., Sen, S., de la Cruz, M. J., Bachovchin, D. A.

Published 2026-10-28
📖 6 min read🧠 Deep dive

Original authors: Tsamouri, L. P., Geeson, M. B., Teplova, M., Li, B., Lai, Z., Tellez, A. V., Ball, D. P., Chakravarti, A., Sen, S., de la Cruz, M. J., Bachovchin, D. A.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Cells are not just static building blocks; they are dynamic entities capable of ending their own lives in different ways, each with a distinct consequence for the body. One common method, known as intrinsic apoptosis, is a quiet, orderly dismantling. When a cell decides to die this way, it opens tiny pores in the outer shell of its mitochondria, the power plants within. This release of internal contents triggers a cascade that breaks the cell down piece by piece, allowing the immune system to ignore the event and move on without inflammation. In contrast, another form of cell death called pyroptosis is a violent, explosive event. It ruptures the cell membrane, spilling inflammatory signals that alert the immune system to danger. The body relies heavily on the quiet version to remove damaged or unnecessary cells without causing a storm of inflammation, but the signals that determine which path a cell takes, and how these two very different processes talk to each other, have remained somewhat mysterious.

A team of researchers at Memorial Sloan Kettering Cancer Center has now uncovered a specific molecular handshake that helps keep this quiet process on track. They discovered that immediately after a cell commits to the quiet death path, two specific proteins—one that acts as a redox sensor and another that functions as a molecular chaperone—work together to lock a third protein into a stable position. This action prevents the cell from accidentally switching to the loud, inflammatory version of death. The study, led by Tsamouri and colleagues, reveals that this mechanism involves a coordinated sequence of events where chemical bonds are formed and broken to ensure the cell dies cleanly.

The story begins with the mitochondria. Inside these organelles, there is a protein called AIFM1, which normally sits anchored to the inner membrane. Under normal conditions, AIFM1 can exist in different shapes, but it often binds to another protein called MIA40, which helps fold other proteins correctly within the mitochondria. However, the researchers found that when a cell receives a death signal, the outer membrane of the mitochondria becomes permeable. This breach allows a protein called oxidized thioredoxin-1, which usually lives in the fluid part of the cell, to rush into the mitochondrial compartment.

Once inside, this oxidized protein does something unexpected. It reaches out and forms a strong, permanent chemical bond with a specific spot on the MIA40 protein. This bond is a disulfide bridge, a type of connection that is very stable under these conditions. The researchers showed that this bond only forms when MIA40 is already attached to AIFM1. By latching onto MIA40, the oxidized protein effectively locks the entire complex into a specific shape. Using high-resolution imaging techniques, the team visualized this structure and saw that the bond forces AIFM1 to pair up with itself, forming a dimer. This dimerization is crucial because it stabilizes the complex and ensures that AIFM1 stays bound to MIA40 rather than switching partners.

There is a competitor in this system. Another protein, called AK2, also wants to bind to AIFM1. If AK2 binds, it could prevent the formation of the stable complex needed for the quiet death process. The researchers found that the cell has a second mechanism to deal with this competition. Shortly after the initial bond forms, an enzyme called DPP8/9, which is active in the cell, begins to chop up the AK2 protein. This degradation removes the competitor, leaving AIFM1 free to remain bound to MIA40. The team demonstrated that if they blocked this enzyme, AK2 remained stable and the complex did not form correctly, suggesting that the removal of AK2 is a necessary step in the process.

The researchers were careful to show that this sequence of events happens very early, right after the mitochondrial membrane opens, and before the cell's internal demolition crew, known as caspases, even begins to work. They tested this by using drugs that induce cell death and by blocking the caspases; the bond formation still occurred. This timing is significant because it suggests the cell has a built-in safety switch that activates immediately upon the decision to die, ensuring the process stays on the quiet track.

Furthermore, the study ruled out several other possibilities. The researchers showed that this bond does not form if the cell is simply stressed by changes in oxygen or temperature; it specifically requires the opening of the mitochondrial membrane. They also found that the bond is not dependent on the overall amount of the oxidized protein in the cell, but rather on the specific moment when the compartments mix. By using genetic engineering to remove key proteins, they confirmed that without the oxidized protein, without MIA40, or without AIFM1, the complex fails to form, and the cell loses this specific layer of control.

The implications of this finding extend beyond just understanding how a cell dies. The proteins involved in this quiet death pathway are the same ones that normally keep the immune system's alarm system, the NLRP1 inflammasome, turned off. When the cell dies quietly, these proteins are busy stabilizing the mitochondrial complex, which keeps the alarm off. However, if this process is disrupted—if the bond cannot form or if the competitor is not removed—the alarm system might get triggered, leading to the loud, inflammatory death instead. The researchers suggest that this mechanism explains how the cell maintains a state of calm during its final moments, and how a failure in this specific redox and proteostasis program could lead to unwanted inflammation.

In essence, the cell uses a two-step strategy to ensure a clean exit. First, it uses a chemical bond to lock a key protein into a stable, dimeric shape. Second, it actively destroys a rival protein that might interfere with this shape. This coordinated effort ensures that the cell's death remains a silent, orderly affair, protecting the surrounding tissue from unnecessary inflammation. The study provides a clear, molecular view of how a cell manages its own end, highlighting a sophisticated layer of regulation that operates independently of the cell's final demolition phase.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →